NASDAQ : VCYT
Veracyte, Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 50.01 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.02B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 3.94B |
| Enterprise Value | 3.49B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 80.39M |
| Shares Outstanding | 80.39M |
| Shares Change (YoY) | +2.11% |
| Shares Change (QoQ) | +0.92% |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 114.06% |
| Float | 79.89M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 35.14 |
| Forward PE | 27.41 |
| PS Ratio | 7.01 |
| Forward PS | 6.34 |
| PB Ratio | 2.84 |
| P/TBV Ratio | 7.31 |
| P/FCF Ratio | 23.73 |
| P/OCF Ratio | 22.08 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 30.52 |
| EV / Sales | 6.22 |
| EV / EBITDA | 30.78 |
| EV / EBIT | 37.70 |
| EV / FCF | 21.05 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 9.16 |
| Quick Ratio | 8.60 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.30 |
| Debt / FCF | 0.24 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 8.77% |
| Return on Assets (ROA) | 4.09% |
| Return on Invested Capital (ROIC) | 9.69% |
| Return on Capital Employed (ROCE) | 6.51% |
| Weighted Average Cost of Capital (WACC) | 14.81% |
| Revenue Per Employee | $744,238 |
| Profits Per Employee | $151,633 |
| Employee Count | 755 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 6.19 |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.54M |
| Effective Tax Rate | 1.32% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.95 |
| 52-Week Price Change | +35.81% |
| 50-Day Moving Average | 44.56 |
| 200-Day Moving Average | 42.86 |
| Relative Strength Index (RSI) | 57.39 |
| Average Volume (20 Days) | 1,170,557 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 9.82M |
| Short Previous Month | 10.18M |
| Short % of Shares Out | 12.22% |
| Short % of Float | 12.29% |
| Short Ratio (days to cover) | 6.64 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 561.90M |
| Gross Profit | 414.44M |
| Operating Income | 92.68M |
| Pretax Income | 116.02M |
| Net Income | 114.48M |
| EBITDA | 113.52M |
| EBIT | 92.68M |
| Earnings Per Share (EPS) | $1.39 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 485.23M |
| Total Debt | 40.11M |
| Net Cash | 445.13M |
| Net Cash Per Share | $5.54 |
| Equity (Book Value) | 1.39B |
| Book Value Per Share | 17.28 |
| Working Capital | 512.04M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 178.38M |
| Capital Expenditures | -12.39M |
| Depreciation & Amortization | 20.83M |
| Net Borrowing | n/a |
| Free Cash Flow | 165.99M |
| FCF Per Share | $2.06 |
Margins
| Measure | Value |
|---|
| Gross Margin | 73.76% |
| Operating Margin | 16.49% |
| Pretax Margin | 20.65% |
| Profit Margin | 20.37% |
| EBITDA Margin | 20.20% |
| EBIT Margin | 16.49% |
| FCF Margin | 29.54% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.11% |
| Shareholder Yield | -2.11% |
| Earnings Yield | 2.85% |
| FCF Yield | 4.21% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $59.73 |
| Price Target Difference | 21.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 12.16% |
| EPS Growth Forecast (3Y) | 5.53% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 18.6 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |